IC

Ikarian Capital Portfolio holdings

AUM $302M
This Quarter Return
+11.95%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$366M
AUM Growth
+$366M
Cap. Flow
+$7.51M
Cap. Flow %
2.05%
Top 10 Hldgs %
50.42%
Holding
132
New
23
Increased
7
Reduced
12
Closed
26

Top Buys

1
ARGX icon
argenx
ARGX
$26.5M
2
XHB icon
SPDR S&P Homebuilders ETF
XHB
$19.1M
3
AMLX icon
Amylyx Pharmaceuticals
AMLX
$12.9M
4
SRPT icon
Sarepta Therapeutics
SRPT
$12.8M
5
ANNX icon
Annexon
ANNX
$12M

Top Sells

1
RCKT icon
Rocket Pharmaceuticals
RCKT
$12.4M
2
AKRO icon
Akero Therapeutics
AKRO
$10.1M
3
IMGN
Immunogen Inc
IMGN
$8.89M
4
PCVX icon
Vaxcyte
PCVX
$7.26M
5
SLRN
ACELYRIN
SLRN
$6.92M

Sector Composition

1 Healthcare 92.55%
2 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
XENE icon
101
Xenon Pharmaceuticals
XENE
$2.99B
– –
0
– –
MORF
102
DELISTED
Morphic Holding, Inc. Common Stock
MORF
– –
0
– –
MOR
103
DELISTED
MorphoSys AG American Depositary Shares
MOR
– –
0
– –
CBAY
104
DELISTED
Cymabay Therapeutics
CBAY
– –
-104,300
Closed -$1.56M
KRTX
105
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
0
– –
ABBV icon
106
AbbVie
ABBV
$374B
– –
0
– –
AKRO icon
107
Akero Therapeutics
AKRO
$3.65B
– –
-200,000
Closed -$10.1M
ALNY icon
108
Alnylam Pharmaceuticals
ALNY
$58.6B
– –
0
– –
AMGN icon
109
Amgen
AMGN
$153B
– –
0
– –
ANVS icon
110
Annovis Bio
ANVS
$44.4M
– –
0
– –
ARE icon
111
Alexandria Real Estate Equities
ARE
$13.9B
– –
0
– –
BHVN icon
112
Biohaven
BHVN
$1.71B
– –
-106,138
Closed -$2.76M
BIVI icon
113
BioVie
BIVI
$12.6M
– –
-457,345
Closed -$1.56M
BMEA icon
114
Biomea Fusion
BMEA
$114M
– –
0
– –
BMRN icon
115
BioMarin Pharmaceuticals
BMRN
$11.3B
– –
0
– –
CLDX icon
116
Celldex Therapeutics
CLDX
$1.57B
– –
0
– –
COGT icon
117
Cogent Biosciences
COGT
$1.83B
– –
-62,766
Closed -$612K
CORT icon
118
Corcept Therapeutics
CORT
$7.52B
– –
0
– –
ETNB icon
119
89bio
ETNB
$1.37B
– –
0
– –
FGEN icon
120
FibroGen
FGEN
$48.4M
– –
-2,774
Closed -$2.39K
FHTX icon
121
Foghorn Therapeutics
FHTX
$298M
– –
-15,292
Closed -$76.5K
IDYA icon
122
IDEAYA Biosciences
IDYA
$2.26B
– –
-216,949
Closed -$5.85M
IMUX icon
123
Immunic
IMUX
$79.4M
– –
-450,000
Closed -$662K
INSM icon
124
Insmed
INSM
$30.3B
– –
-154,900
Closed -$3.91M
JAZZ icon
125
Jazz Pharmaceuticals
JAZZ
$7.99B
– –
0
– –
2 3 4
5
6